Article Text
Abstract
INTRODUCTION
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited, autosomal dominant condition with high penetrance and varying expression. It is an important cause of protracted disability in young adults, with recurrent strokes, psychiatric dysfunction, and dementia. Although some families were identified in the 1950s, the syndrome was characterized and named only in 1993. The prevalence remains unknown, but numbers are increasing in parallel with wider medical recognition.
GENETICS, PATHOLOGY AND PATHOPHYSIOLOGY
CADASIL is caused by mutations in the Notch3 gene (chromosome 19p13) (Joutel et al. 1996), which encodes a large single-pass transmembrane receptor. The receptor’s extracellular domain contains 34 epidermal growth factor-like tandem repeats (EGF repeats). This receptor is part of a highly conserved signalling pathway that is essential for normal maturation of blood vessels in both fetal and adult brain, and is maximally expressed in small to medium penetrating arteries in early postnatal development
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Abnormal sensorimotor plasticity in CADASIL correlates with neuropsychological impairment
- Impaired vasoreactivity in mildly disabled CADASIL patients
- Notch3 gene polymorphism and ischaemic cerebrovascular disease
- Non-convulsive status epilepticus causing focal neurological deficits in CADASIL
- Non-convulsive status epilepticus causing focal neurological deficits in CADASIL
- Functional analysis of a recurrent missense mutation in Notch3 in CADASIL
- No association between multiple sclerosis and the Notch3 gene responsible for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
- 7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL
- CADASIL: how to avoid the unavoidable?
- Description of a simple test for CADASIL disease and determination of mutation frequencies in sporadic ischaemic stroke and dementia patients